Pharmaceutical Drug Targets and Diseases: Difference between revisions
David Canner (talk | contribs) No edit summary |
David Canner (talk | contribs) No edit summary |
||
Line 20: | Line 20: | ||
**Autoimmune Diseases | **Autoimmune Diseases | ||
***[[Prolyl Endopeptidase]] | |||
***[[Tumor Necrosis Factor Receptor]] | ***[[Tumor Necrosis Factor Receptor]] | ||
***[[Molecular_Playground/TRAIL|Tumor-Necrosis Factor Apoptosis-Inducing Ligand]] | ***[[Molecular_Playground/TRAIL|Tumor-Necrosis Factor Apoptosis-Inducing Ligand]] |